GSK Investigational Site

La Laguna (Santa Cruz de Tenerife) 38320

0 studies enrolling now · 5 studies all time

What they study most

Infection, Human Immunodeficiency Virus I, Metastatic Cervical Cancer, Neoplasms, Breast, Neoplasms, Prostate, Neoplasms, Uterine Cervix

Studies at this site

• A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily — Completed
• A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer — Completed
• Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer — Completed